NASDAQ:ADAP

Adaptimmune Therapeutics Stock Forecast

etoro logo Buy ADAP
*Your capital is at risk
$0.0549
+0 (+0%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of ADAP
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Adaptimmune Therapeutics plc stock after losing 0%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Oct 29, 2025

No changes to the price of Adaptimmune Therapeutics plc stock on the last trading day (Monday, 17th Nov 2025). During the last trading day the stock fluctuated 0% from a day low at $0.0549 to a day high of $0.0549. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0287 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.09% during the next 3 months and, with a 90% probability hold a price between $0.0296 and $0.230 at the end of this 3-month period.

ADAP Signals & Forecast

There are mixed signals in the stock today. The Adaptimmune Therapeutics plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0549 and $0.101. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, October 27, 2025, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Friday, August 22, 2025 and based on theory for this formation the price should go up by 9.84% to $0.0603 within 2 trading days (Tuesday, August 26, 2025) since signal was issued.

Support, Risk & Stop-loss for Adaptimmune Therapeutics plc stock

Adaptimmune Therapeutics plc finds support from accumulated volume at $0.0526 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0516 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (ADAP) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Adaptimmune Therapeutics plc to open at $0.0549, and during the day (based on 14 day Average True Range), to move between $0.0489 and $0.0609, which gives a possible trading interval of +/-$0.0119 (+/-24.41%) up or down from last closing price. If Adaptimmune Therapeutics plc takes out the full calculated possible swing range there will be an estimated 24.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0526 (4.19%) than the resistance at $0.0590 (7.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Adaptimmune Therapeutics plc stock A Buy?

Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.0549 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

ADAP Performance

Trading levels for ADAP

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0549 -
R2 0.0549 -
R1 0.0549 -
Price 0.0549
S1 0.0549 -
S2 0.0549 -
S3 0.0549 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0666 21.31%
R2 0.0597 8.74%
R1 0.0590 7.47%
Price 0.0549
S1 0.0526 -4.19%
S2 0.0510 -7.10%
S3 0.0486 -11.48%

FAQ

What is the symbol for Adaptimmune Therapeutics plc Stock and on which exchange is it traded?
The symbol for Adaptimmune Therapeutics plc is ADAP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.

What's the current price of Adaptimmune Therapeutics plc Stock?
As of the end of day on the Nov 17, 2025, the price of an Adaptimmune Therapeutics plc (ADAP) share was $0.0549.

What is the 52-week high and low for Adaptimmune Therapeutics plc Stock?
The 52-week high for Adaptimmune Therapeutics plc Stock is $0.740 and the 52-week low is $0.0403.

What is the market capitalization of Adaptimmune Therapeutics plc Stock?
As of the Nov 17, 2025, the market capitalization of Adaptimmune Therapeutics plc is 85.075M.

When is the next earnings date for Adaptimmune Therapeutics plc?
The upcoming earnings date for Adaptimmune Therapeutics plc is Mar 18, 2026.
Click to get the best stock tips daily for free!
ABOUT ADAPTIMMUNE THERAPEUTICS PLC
Adaptimmune Therapeutics
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE